Skip to main content

Lichen International Ltd

corporate_fare Company Profile

Lichen International Ltd

LICN·NASDAQ·Trade & Services·CIK 0001876766

Lichen International Limited is a holding company that controls and receives economic benefits from its subsidiaries' business operations, primarily through equity ownership in its PRC subsidiaries. The company was incorporated on April 13, 2016, in the Cayman Islands. As of the date of this annual report, its authorized share capital is US$200,000,000, divided into 20,000,000,000 Class A Ordinary Shares and 5,000,000,000 Class B Ordinary Shares. Of these, 16,326,825 Class A Ordinary Shares and 110,000 Class B Ordinary Shares are issued and outstanding. The company's main operating entity is Lichen Zixun, established on April 14, 2004, under the laws of the PRC, and is a wholly owned subsidiary of Legend Consulting HK. Legend Consulting HK was formed on January 8, 2014, in Hong Kong, and is a wholly owned subsidiary of Legend Consulting BVI. Legend Consulting BVI, incorporated on December 20, 2013, in the British Virgin Islands, is a wholly owned subsidiary of Lichen International Limited. Other subsidiaries include Lichen Singapore, established on December 28, 2023, in Singapore, and Bondly HK, established on June 13, 2022, in Hong Kong. Bondly XM was established on August 25, 2022, in the PRC, and is a wholly owned subsidiary of Bondly HK. Lichen Yingtan is an investment holding company wholly owned by Legend Consulting HK. Legend Technology, wholly owned and established by Lichen Zixun on July 9, 2025, provides technology promotion and application services.

Lichen International Ltd (NASDAQ:LICN) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 7 items for LICN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 8/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for LICN spans 6-K, 424B5, 20-F.

Recent high-impact activity:

  • Lichen Closes $3.5M Offering at $0.20; Warrants Already Exercised for 28.9M Shares
  • Lichen Prices $3.5M Unit Offering at $0.20 — 76% Below Last Sale, Warrants Cover Up to 100.1M Shares
  • Lichen Prices $3.5M Offering at $0.20, a 150% Premium to $0.08 Trading Price
  • Lichen Sets Nov 9 EGM for 100-for-1 Reverse Split to Avoid Nasdaq Delisting
  • Lichen International Posts $11.5M H1 Loss as Revenue Falls 28% Amid AI Pivot

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$809K
Net Income
-$21.96M
Diluted EPS
-$4.11
Op. Cash Flow
-$17.85M
Free Cash Flow
-$17.85M
Gross Profit
$9.14M
Operating Income
-$18.07M
Cash & Equivalents
$26.91M
Debt / Equity
0.00×
Net Margin
-27.15×
Shares Outstanding
5.3M sh
Source: 20-F · filed 2026-04-28 · accession 0001185185-26-001520

Short Interest & Short Volume

3.28 days to cover

FINRA reported short interest of 101,080 shares in LICN as of the October 30, 2026 settlement, a 28.2% decrease from the prior period — about 3.3 days to cover at its recent average daily volume. On November 20, 2026, 65.4% of LICN volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)101,080 shares as of October 30, 2026
Change vs prior period▼ 28.2%
Days to cover3.28 at avg daily volume of 30,788
Daily short volume (FINRA facilities)65.4% of 98,201 shares on November 20, 2026
5-day average short volume53.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for LICN, detected from its recent SEC filings · based on capital-structure filings through 2026-11-10.

1 recent capital raisereverse split

Unit Offering Priced at $0.20 · Warrants Add Massive Overhang

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Insider Transactions

LICN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with L →
$1.27 -1.52% today
52-week range · as of 2026-11-12 $0.0329 – $9.49
Market cap
$351.1K
Volume
229.5K (0.7× avg)
3-mo avg 350.9K
Live data · 2026-11-21 14:29 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LICN - Latest Insights

LICN
Nov 12, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.0336
Real-time Price: $1.27 info
Change: Reverse Stock Split info
Market Cap: $351.097K info
LICN
Nov 10, 2026, 5:31 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.045
Real-time Price: $1.27 info
Change: Reverse Stock Split info
Market Cap: $351.097K info
LICN
Nov 10, 2026, 8:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.080
Real-time Price: $1.27 info
Change: Reverse Stock Split info
Market Cap: $351.097K info
LICN
Oct 23, 2026, 6:03 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.9415
Real-time Price: $1.27 info
Change: Reverse Stock Split info
Market Cap: $351.097K info
LICN
Sep 30, 2026, 4:31 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.02
Real-time Price: $1.27 info
Change: Reverse Stock Split info
Market Cap: $351.097K info
LICN
Apr 28, 2026, 4:31 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $4.00
Real-time Price: $1.27 info
Change: Reverse Stock Split info
Market Cap: $351.097K info
LICN
Jan 07, 2026, 5:00 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $3.13
Real-time Price: $1.27 info
Change: Reverse Stock Split info
Market Cap: $351.097K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets